Cite
HARVARD Citation
Torrebadell, M. et al. (2018). A 4-gene expression prognostic signature might guide post-remission therapy in patients with intermediate-risk cytogenetic acute myeloid leukemia. Leukemia & lymphoma. 59 (10), pp. 2394-2404. [Online].